1. Home
  2. KWY vs NNNN Comparison

KWY vs NNNN Comparison

Compare KWY & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kingsway Corporation Common Stock

KWY

Kingsway Corporation Common Stock

N/A

Current Price

$9.40

Market Cap

283.2M

Sector

Finance

ML Signal

N/A

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$6.30

Market Cap

270.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KWY
NNNN
Founded
1989
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
283.2M
270.4M
IPO Year
2013
2023

Fundamental Metrics

Financial Performance
Metric
KWY
NNNN
Price
$9.40
$6.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
29.4K
★ 228.0K
Earning Date
11-05-2026
10-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $134,996,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$446.57
Revenue Growth
★ 23.42
N/A
52 Week Low
$8.41
$5.13
52 Week High
$11.36
$51.33

Technical Indicators

Market Signals
Indicator
KWY
NNNN
Relative Strength Index (RSI) 45.05 43.64
Support Level $8.41 $5.13
Resistance Level $9.60 $6.95
Average True Range (ATR) 0.33 0.52
MACD -0.02 0.21
Stochastic Oscillator 39.34 66.48

Price Performance

Historical Comparison
KWY
NNNN

About KWY Kingsway Corporation Common Stock

Kingsway Corp is a U.S.-based company employing the Search Fund model to acquire and build great businesses. The company owns and operates a collection of B2B and B2C services companies that are asset-light, growing, profitable, and that have recurring revenues. It seeks to compound long-term shareholder value on a per share basis via its decentralized management model, its talented team of operators, and its tax-advantaged corporate structure.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: